Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Phase III Trial of Molecular Profile-based Versus Standard Recommendations for Adjuvant Radiotherapy for Women With Early Stage Endometrial Cancer: PORTEC-4a Trial

NCT03469674 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT03469674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03469674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Phase III Trial of Molecular Profile-based Versus Standard Recommendations for Adjuvant Radiotherapy for Women With Early Stage Endometrial Cancer: PORTEC-4a Trial
Lead sponsor
Leiden University Medical Center
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 10, 2016
Completion date
December 31, 2028
Enrollment
550 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer stage i, endometrial cancer stage ii